Zhengqing means to eliminate evil and chaos, and to avoid chaos. The relevant content is as follows:
1. Source:
"Han Shu·Biography of Ku Li·Yan Yannian": "When orders are enforced and prohibited, the county is in good order." "Book of the Later Han·Five Elements Chronicles One": "At all times, Shan Chao, Zuo Ming, Xu Huang, Ju Yuan, and Tang Heng were often at the emperor's side, allowing them to be treacherous... Emperor Huan died due to the solar eclipse. In order to change, he worshiped the late Situ Han Yin as the commander of the Sili School, and then punished him, Zhengqing in Kyoto."
2. Zhengqing Enterprise:
Zhengqing is Hunan Zhengqing Pharmaceutical Group Co., Ltd. The company's brand. Hunan Zhengqing Pharmaceutical Group Co., Ltd. was founded in 1992, with total assets of 456 million yuan, net assets of 350 million yuan, and 1,200 employees. The group's holding and joint-stock companies include Huaihua Zhizhao Pharmaceutical Co., Ltd., Hunan Zhengchi Pharmaceutical Co., Ltd., Hunan Zhengyuan Biological Resources Development Co., Ltd., Huaihua Automobile Training School No. 3, etc.
Dr. Wu Feichi, the founder and chairman of Zhengqing Group, is a representative of the Hunan Provincial People’s Congress, a winner of the National May 1st Labor Medal, and an expert who enjoys special government allowances from the State Council. Under his leadership, Zhengqing Group has developed from a small workshop-style pharmaceutical factory to one of the top ten high-tech enterprises in Hunan Province.
It is a national high-tech demonstration enterprise for the modernization of traditional Chinese medicine and a national key leading enterprise in agricultural industrialization. It has the first corporate postdoctoral research workstation in China that specializes in the study of the spectral efficacy of Houttuynia cordata. It is a key high-tech enterprise and a key enterprise in Hunan Province. One of the four major pharmaceutical companies in Hunan Province.
As one of the pharmaceutical companies with the most complete GMP-passed dosage forms in the country, Zhengqing has devoted itself to creating five major product series in accordance with the "3 1 n" product portfolio model: the first domestic Chinese medicine sustained-release patented drug—— The anti-rheumatic drug series represented by Zhengqing Fengtongning Sustained Release Tablets; the traditional Chinese medicine injection series represented by Boxer Grass TM Houttuynia Cordata Injection.
Zhengqing has always insisted on taking independent innovation as the driving force to improve the core competitiveness of enterprises. Relying on independent innovation, it has cultivated the Zhengqing brand in the fierce market competition, established a solid market network, and achieved significant economic benefits. and social benefits, the total assets have expanded from 4.7 million yuan to 456 million yuan, and the company has achieved extraordinary development.
It has applied for 35 national patents, including 24 invention patents, and developed more than 30 national-level new drugs such as Zhengqing Fengtongning, Ganoderma lucidum oral liquid, and Doctor's grass. It has more than 300 drug production approval documents, 69 of which are independent innovations and 27 of which are domestically leading. ?